One of the primary challenges is that pharma cold chain logistics are predicated on multifaceted operations. From production to distribution and cold chain vaccine storage, medicines need strict temperature monitoring, with a short window for warmer temperatures before these are said to be contaminated or ineffective. When it comes to temperature monitoring, the biopharma industry loses around $35 billion annually due to temperature control failures. This situation is poised for change.
When vaccine containers are damaged, exposed to undesirable temperatures, this is called closed vial wastage. Open vial wastage happens when a vaccine is opened and the balance of the doses aren’t used timeously or stored correctly. All forms of wastage have a knock-on effect, putting pressure on nodes all along the vaccine supply chain.
Personnel working across all nodes (sometimes in different locations around the world) need to co-ordinate carefully to avoid issues around production schedules and deliveries, stock shortages, unfulfilled demand, bottlenecks, vaccination accessories, and so on. This demands the creation of optimal processes and full transparency.